Conestoga Capital Advisors LLC Sells 1,040 Shares of West Pharmaceutical Services, Inc. (NYSE:WST)

Conestoga Capital Advisors LLC trimmed its stake in West Pharmaceutical Services, Inc. (NYSE:WST – Free Report) by 1.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 55,353 shares of the medical instruments supplier’s stock after selling 1,040 shares during the period. Conestoga Capital […]

Related Keywords

Chad ,Silji Abraham ,Asia Pacific ,Artisan Partners Limited Partnership ,Vanguard Group Inc ,Quarter For West Pharmaceutical Services ,T Rowe Price Investment Management Inc ,Keycorp ,Geode Capital Management ,Services Trading Down ,Conestoga Capital Advisors ,Securities Exchange Commission ,Jefferies Financial Group ,Services Dividend Announcement ,News Ratings For West Pharmaceutical Services Daily ,Brown Advisory Inc ,Services Inc ,Exchange Commission ,West Pharmaceutical Services ,Free Report ,Capital Advisors ,Rowe Price Investment Management ,Partners Limited Partnership ,Capital Management ,Brown Advisory ,Pharmaceutical Services Trading Down ,Pharmaceutical Services ,Get Free Report ,Financial Group ,West Pharmaceutical ,Middle East ,Proprietary Products ,Visit Holdingschannel ,West Pharmaceutical Services Daily ,Nyse Wst ,Wst ,Medical ,95530610 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,